Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemia

OBJECTIVE: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease in terms of survival with and without treatment. Many chemo and immunotherapeutic agents are available to treat this indolent disease. Aim of this study was to determine the outcomes of patients with chronic lymphocytic leukemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazir, Adil, Fawad, Ali, Sheeraz, Badar, Farhana, Siddique, Neelam, Hameed, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103136/
https://www.ncbi.nlm.nih.gov/pubmed/27882024
http://dx.doi.org/10.12669/pjms.325.10480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103136/
https://www.ncbi.nlm.nih.gov/pubmed/27882024
http://dx.doi.org/10.12669/pjms.325.10480

Ejemplares similares